Bayesian Capital Management’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
CIP
AR
ICOM
Bayesian Capital Management's LDL Position: Q1 2017 in Review
Bayesian Capital Management sold out of Lydall, Inc. (LDL) in Q1 2017, closing a stake of 3,581 shares — an estimated $221K sold.
Bayesian Capital Management first reported a position in LDL in Q4 2016 and held it in 1 quarter. The position peaked at $221K in Q4 2016. 152 funds tracked by Wall St. Rank hold LDL as of Q1 2017.
- Bayesian Capital Management reported no remaining Lydall, Inc. position as of Q1 2017 after selling out during the quarter.
- Bayesian Capital Management sold 3,581 Lydall, Inc. shares in Q1 2017, an estimated $221K.
- Bayesian Capital Management first reported a position in Lydall, Inc. in Q4 2016 and held it in 1 quarter.
- Bayesian Capital Management's Lydall, Inc. position peaked at $221K in Q4 2016.
- 152 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2017.
Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.